FLA | Jotup

Broward County Library Honored for Championing Intellectual Freedom

Retrieved on:

星期三, 五月 8, 2024

Freedom to Read Foundation, Broward County Library, Library, Conference, Freedom, Environment, Intellectual freedom, Rights, FLA, Book

BROWARD COUNTY, Fla., May 8, 2024 /PRNewswire/ -- Broward County Library Director Allison Grubbs and the library itself are both receiving prestigious awards for their unwavering commitment to intellectual freedom and access to information for all.

Key Points:

BROWARD COUNTY, Fla., May 8, 2024 /PRNewswire/ -- Broward County Library Director Allison Grubbs and the library itself are both receiving prestigious awards for their unwavering commitment to intellectual freedom and access to information for all.
These honors recognize her exceptional leadership in championing intellectual freedom and diverse perspectives within the library as well as for expanding access to library programs and services, supporting statewide library advocacy efforts and for her leadership within the professional community.
Under Grubbs' direction, Broward County Library has fostered a vibrant and inclusive environment, earning the FLA's 2024 Intellectual Freedom Award.
"These awards are a testament to the library's unwavering commitment to intellectual freedom," said Broward County Administrator Monica Cepero.

CLS Americas Announces 2nd Order of TRANBERG™ Focal Laser Ablation Accessories Placed by the National Institutes of Health Clinical Center

Retrieved on:

星期二, 四月 9, 2024

Diagnosis, Temperature, Urology, Prostate cancer, Patient, NIHCC, FLA, NIH, Male, Urinary incontinence, Erectile dysfunction, CLS, Bangladesh Technical Education Board, Medical imaging

LOS ANGELES, April 09, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced it has received its second order from the National Institutes of Health Clinical Center (NIHCC) for its TRANBERG™ Thermal Therapy System accessories.

Key Points:

LOS ANGELES, April 09, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced it has received its second order from the National Institutes of Health Clinical Center (NIHCC) for its TRANBERG™ Thermal Therapy System accessories.
The order falls under the previously announced research collaboration agreement between NIHCC and its parent company, Clinical Laserthermia Systems AB, based in Sweden.
“This second order of our TRANBERG Focal Laser Ablation accessories enables our continued collaboration with the NIH to evaluate our TRANBERG laser for image-guided, focal therapies to treat prostate cancer,” said Michael Magnani, President of CLS Americas.
It includes a desk-top mobile laser unit, innovative non-cooled laser applicators, tissue temperature probes, and procedure-specific accessories.

CLS Americas Announces ROSE Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation

Retrieved on:

星期四, 三月 28, 2024

Diagnosis, Temperature, Urology, Prostate cancer, Patient, Cancer, Prostate, FLA, Urinary incontinence, Erectile dysfunction, CLS, FDA, Physician, Medical imaging

LOS ANGELES, March 28, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced that ROSE Urology, LLC , located in Vero Beach, Florida, will begin using the TRANBERG™ Thermal Therapy System to treat prostate cancer patients.

Key Points:

LOS ANGELES, March 28, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced that ROSE Urology, LLC , located in Vero Beach, Florida, will begin using the TRANBERG™ Thermal Therapy System to treat prostate cancer patients.
The system is FDA 510(k) cleared for soft tissue ablation in a urology setting.
Operating under CLS's Mobile Services Agreement, CLS will provide its FDA 510(k) cleared TRANBERG Laser, consumable accessories, training, and on-site clinical and technical support to ROSE Urology physicians and staff during procedures.
Focal laser ablation of prostate tumors has demonstrated high levels of precision and accuracy with low risk of side effects, such as erectile dysfunction and urinary incontinence.

HuLoop Wins ICBA ThinkTECH Accelerator MVP Award, Bankers Choice Award

Retrieved on:

星期六, 三月 16, 2024

Automation, Participation, MVP, Bank, Cognitive computer, FLA, Independent, ICBA, AI, Fiserv, Accelerator, Most, AP6, Data management, Medical device

AUBURN, Calif., March 16, 2024 /PRNewswire/ -- HuLoop Automation (HuLoop), an emerging AI-based intelligent automation software leader, was recognized by the Independent Community Bankers of America (ICBA) during its ThinkTECH Showcase at ICBA LIVE in Orlando Fla. HuLoop, a participant in ICBA's award-winning ThinkTECH Accelerator program was named Most Valuable Participant (MVP) and also selected as this year's Banker's Choice recipient.

Key Points:

AUBURN, Calif., March 16, 2024 /PRNewswire/ -- HuLoop Automation (HuLoop), an emerging AI-based intelligent automation software leader, was recognized by the Independent Community Bankers of America (ICBA) during its ThinkTECH Showcase at ICBA LIVE in Orlando Fla. HuLoop, a participant in ICBA's award-winning ThinkTECH Accelerator program was named Most Valuable Participant (MVP) and also selected as this year's Banker's Choice recipient.
The MVP award, sponsored by TrueNorth, recognizes the most-evolved fintech offering based on program engagement and alignment with community bank business priorities.
The Banker's Choice Award, sponsored by Fiserv, is selected by an audience vote during the ICBA ThinkTECH Showcase following seven-minute pitches from member of its latest cohort (AP6).
"HuLoop is grateful to receive both the MVP and Banker's Choice awards as recognition for the invaluable feedback we received through the ICBA ThinkTECH Accelerator program and its dedication to developing solutions that truly help community banks thrive," HuLoop President and CEO Todd Michaud said.

EcoVadis Awards EcoPlum its Silver Sustainability Medal and Top 10% Rating Among Companies Scored

Retrieved on:

星期四, 二月 29, 2024

Sustainability, NYS, Plastic Pollution Coalition, Investment, CSR, FLA, PPC, Risk, Plastic, ASI, Advertising Specialty Institute, Fair Labor Association, Tourism

NEW YORK, Feb. 29, 2024 /PRNewswire-PRWeb/ -- EcoPlum, a sustainable promotional products company and certified B Corporation, announces that it has been awarded the EcoVadis Silver Medal sustainability rating.

Key Points:

NEW YORK, Feb. 29, 2024 /PRNewswire-PRWeb/ -- EcoPlum, a sustainable promotional products company and certified B Corporation, announces that it has been awarded the EcoVadis Silver Medal sustainability rating.
"Earning the EcoVadis Silver Sustainability Medal is a major milestone for EcoPlum and recognizes the investments we have made in integrating sustainable business practices into everything we do as a company," says Gia Machlin, EcoPlum President and CEO.
EcoPlum placed in the top 10% of all companies rated by EcoVadis , in completing its first sustainability assessment with the organization.
The scorecard demonstrates performance in 21 indicators across four broad themes:
The new EcoVadis Silver Medal certification is the latest in many certifications held by EcoPlum.

CLS Americas Selects Quest International to Provide Aftermarket Service and Logistics Operations for TRANBERG Laser Ablation System

Retrieved on:

星期二, 十一月 28, 2023

ED, Quest International, Risk, FLA, Service, Quest, Prostate cancer, Original equipment manufacturer, Urinary incontinence, CLS, Growth, Diagnosis, Urology, Erectile dysfunction, Medical imaging

LOS ANGELES, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced it has selected Quest International , a global aftermarket technical service provider to OEMs, to provide Service and Logistics Operations for the US market.

Key Points:

LOS ANGELES, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced it has selected Quest International , a global aftermarket technical service provider to OEMs, to provide Service and Logistics Operations for the US market.
Under the agreement, Quest will provide end to end white glove service management including field services, depot repair, and warehousing and logistics support for CLS’s TRANBERG Thermal Therapy System , a 510(k) medical device for soft tissue ablation.
The CLS TRANBERG System provides safe and effective focal laser ablation of low-to-medium risk prostate tumors, while also preserving healthy tissue to minimize the risk of unwanted side effects such as ED and urinary incontinence.
“CLS Americas is very pleased to partner with Quest International and its excellent reputation and expertise in all aspects of aftermarket service and logistics operations,” stated Michael Magnani, president of CLS Americas.

Notable Labs Announces JCO Precision Oncology Publication Demonstrating PPMP Potential to Identify Novel Drug Combinations in JMML

Retrieved on:

星期四, 十一月 9, 2023

FOSTER CITY, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Inc. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced the publication of data from an ex vivo study demonstrating the potential for its Predictive Precision Medicine Platform (PPMP) to identify more effective pre-hematopoietic stem cell transplantation (pre-HSCT) regimens for the treatment of juvenile myelomonocytic leukemia (JMML) in the November 9th Issue of the American Society of Clinical Oncology (ASCO) Journal JCO Precision Oncology. Part of this data was recently presented at the European Hematology Association (EHA) Hybrid Congress held in Frankfurt, Germany on June 8 – 15, 2023. Details of that presentation can be found on the Company’s website at https://notablelabs.com/.

Key Points:

JMML is a rare, aggressive pediatric malignancy for which curative treatment is restricted to hematopoietic stem cell transplantation.
Pre-HSCT therapies, i.e., therapies prior to transplantation, include moderately intensive chemotherapy (particularly fludarabine and cytarabine in combination (FLA)) and azacytidine (AZA) monotherapy.
Applying its proprietary PPMP technology to blood or bone marrow samples from JMML patients, Notable screened 130 drug combinations and discovered that 27 of these combinations (26 dual-, 1 triple-combination) were more effective ex vivo than the components of these combinations tested individually.
“This publication marks the culmination of a multi-year collaboration between UCSF and Notable Labs,” remarked Dr. Stieglitz.

Taking Stock of Fashion's Progress towards Net Positive: Industry organisations consolidate sustainability guidance and present new data

Retrieved on:

星期四, 十一月 30, 2023

The second GFA Monitor has been updated to include the latest guidance and insights from over 25 industry organisations in one cohesive publication.

Key Points:

The second GFA Monitor has been updated to include the latest guidance and insights from over 25 industry organisations in one cohesive publication.
For the first time, the report includes new data insights from the Fashion Industry Target Consultation - drawn from over 900 industry participants in 90 countries.
GFA welcomes further cooperation with other industry organisations as the annual report evolves and responds to industry and scientific developments.
Scott Raskin, CEO, Worldly, Data Partner for The GFA Monitor, says: "To address climate change, the apparel industry needs primary supply chain data at scale.

Taking Stock of Fashion's Progress towards Net Positive: Industry organisations consolidate sustainability guidance and present new data

Retrieved on:

星期四, 十一月 30, 2023

The second GFA Monitor has been updated to include the latest guidance and insights from over 25 industry organisations in one cohesive publication.

Key Points:

The second GFA Monitor has been updated to include the latest guidance and insights from over 25 industry organisations in one cohesive publication.
For the first time, the report includes new data insights from the Fashion Industry Target Consultation - drawn from over 900 industry participants in 90 countries.
GFA welcomes further cooperation with other industry organisations as the annual report evolves and responds to industry and scientific developments.
Scott Raskin, CEO, Worldly, Data Partner for The GFA Monitor, says: "To address climate change, the apparel industry needs primary supply chain data at scale.

CLS Americas States KASRAEIAN Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation

Retrieved on:

星期四, 十一月 9, 2023

FDA, Erectile dysfunction, CLS, Temperature, FLA, Urology, Physician, Organization, Prostate cancer, FACS, Prostate, Microsoft mobile services, Cancer, Patient, Diagnosis, Urinary incontinence, Medical imaging

LOS ANGELES, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced that KASRAEIAN Urology located in Jacksonville, FL, will begin treating prostate cancer patients using the TRANBERG™ Thermal Therapy System to provide focal laser ablation treatments.

Key Points:

LOS ANGELES, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced that KASRAEIAN Urology located in Jacksonville, FL, will begin treating prostate cancer patients using the TRANBERG™ Thermal Therapy System to provide focal laser ablation treatments.
In the US, over one million prostate biopsies are performed every year leading to a diagnosis of prostate cancer for almost 250,000 men.
“We look forward to adding the TRANBERG focal laser ablation treatment option for our low-to-intermediate risk prostate cancer patients.
It allows them to gain access to our image-guided TRANBERG focal laser ablation system without any capital equipment expense,” said Michael Magnani, president of CLS Americas.